Altria pays one of the largest dividends in the S&P 500. The yield sits near 6%, more than four times what the index average pays. For income investors, that number is the whole pitch.
The catch is what stands behind it. Altria sells fewer cigarettes every year, and the gap between a falling core business and a rising dividend is the real story for anyone who owns the stock or is thinking about it.
The streak that built the reputation
Altria (MO) is the company behind Marlboro, the best-selling cigarette brand in the United States. It also owns Black & Mild cigars, the Copenhagen and Skoal smokeless brands, and the on! line of nicotine pouches.
The stock trades near $70 with a market cap around $116 billion. The current annual dividend is $4.24 per share, paid in quarterly installments of $1.06. Altria lifted the payout 3.9% in 2025, its 60th increase in 56 years.
That track record puts Altria in a small club called the Dividend Kings, companies that have raised their dividend for at least 50 years straight. Very few businesses survive that long, let alone keep handing shareholders more cash every single year.
How Altria affords the check
The engine is Marlboro's pricing power. Even as fewer Americans smoke, the ones who do tend to keep buying their brand, and Altria raises prices enough to grow revenue per pack faster than volumes shrink. Cigarettes throw off huge cash with almost no factory reinvestment.
That cash is what funds the dividend. Management aims to send roughly 80% of adjusted earnings back out as a dividend, one of the highest payout targets of any large US company. The actual ratio has at times run above that level.
A high payout is a double-edged tool. It hands shareholders a fat yield now, but it leaves little cushion. If profit slips, there is not much room left before the dividend swallows everything the company earns. Altria's low beta of about 0.5 means the stock moves less than the market, which is part of why income investors hold it through rough tape.
The core keeps shrinking
The problem is volume. US cigarette shipments have fallen for decades, and the decline is speeding up. Altria's cigarette unit sales dropped close to 10% last year, a steeper drop than the low-to-mid single-digit slides the industry counted on for years.
Price hikes can offset some of that, but not forever. Each year there are fewer smokers to raise prices on. At some point the volume losses outrun what higher prices can recover, and the cash machine behind the dividend starts to slow.
This is the tension every Altria buyer signs up for. The yield is real and the history is real, but both rest on a product the country uses less of every year.
The smoke-free bet
Altria's answer is to move customers to products that do not burn. Its on! nicotine pouches compete with the category leader, and a newer version called on! PLUS reached nationwide store shelves in March 2026 after clearing an FDA review pilot. The company also owns NJOY, an e-vapor brand with FDA-authorized products.
So far the shift is slow. Oral tobacco revenue grew less than 1% recently, not nearly fast enough to replace the lost cigarette sales. The smoke-free push is the right idea, but it is years from carrying the company.
That is the number to watch. If pouches and vapor start growing fast enough to offset the cigarette decline, the dividend gets safer. If they stall, the payout ratio keeps climbing toward its ceiling.
What you pay versus what you get
The market treats Altria as a slow-melting cash cow, and it prices it that way. The stock changes hands at roughly 12 to 13 times expected earnings, a steep discount to the broad market.
The contrast with its former international arm is sharp. Philip Morris (PM) trades near $176 with a market cap around $275 billion and yields under 4%, well below Altria. Investors pay a much higher multiple for Philip Morris because its Zyn pouches and IQOS heated-tobacco devices are growing fast overseas. Altria gets the cheaper multiple and the bigger yield because its growth story is still unproven at home.
That is the trade in one line. Altria offers more income today for less growth tomorrow. Philip Morris offers the reverse.
What it comes down to
Altria is a high-yield stock for investors who want cash now and can accept a business that gets a little smaller each year. The 56-year streak is not an accident, and the company has defended the dividend through worse stretches than this one.
The question is no longer whether the dividend is large. It is whether the smoke-free brands can grow fast enough to keep the payout ratio from running out of room. Watch the pouch numbers and the payout ratio over the next several quarters. Those two figures, more than the headline yield, will tell income investors whether the streak has another decade in it.
